Publications by authors named "Marija Todorovic Markovic"
Article Synopsis
- The study investigated mortality rates among patients with community-acquired infections at the National Hospital of the Faroe Islands from October 2013 to April 2015, involving data collection on patient outcomes.
- Researchers calculated various mortality rates and created survival curves to compare infected and non-infected patients, utilizing statistical methods like the log-rank test and Cox regression models.
- Findings showed that patients with severe infections had higher cumulative and short-term mortality rates compared to those without infections, but no significant differences were observed in intermediate or long-term survival rates after adjusting for age and sex.
Background: The aim of the present study was to gain national data on the clinical and microbiological characteristics of community-acquired infections in the Faroe Islands and to compare these data with data from other geographical areas.
Methods: A prospective, observational study involving all patients > = 16 years admitted at the Department of Medicine at the National Hospital, Torshavn, Faroe Islands from October 2013 until April 2015.
Results: Of 5279 admissions, 1054 cases were with community-acquired infection and were included in the study.
Introduction: The aim of the study was to gather nation-wide epidemiological and clinical data in order to characterize community-acquired sepsis in the Faroe Islands, and to compare these data with epidemiological studies performed in other geographical areas.
Methods: A prospective, observational study conducted from October 2013 until April 2015 to characterize sepsis, and to calculate incidence rates for community-acquired sepsis of any severity, community-acquired severe sepsis, community-acquired septic shock and community-acquired sepsis without community-acquired severe sepsis or community-acquired septic shock.
Results: Of 5279 admissions, 583 cases fulfilled the criteria for community-acquired sepsis of any severity.